147 related articles for article (PubMed ID: 37104886)
21. Diagnostic accuracy of electrically elicited multiplet discharges in patients with motor neuron disease.
Sleutjes BT; Montfoort I; van Doorn PA; Visser GH; Blok JH
J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1234-9. PubMed ID: 25540246
[TBL] [Abstract][Full Text] [Related]
22. A prospective study for using cognitive decline as a predictor for survival and use of feeding/respiratory support for patients with motor neuron disease in Norway.
Taule T; Tysnes OB; Aßmus J; Rekand T
Ann Palliat Med; 2024 Jan; 13(1):86-92. PubMed ID: 38316400
[TBL] [Abstract][Full Text] [Related]
23. Variation in assistive technology use in Motor Neuron Disease according to clinical phenotypes and ALS Functional Rating Scale - Revised Score: A prospective observational study.
Connors K; Mahony L; Morgan P
NeuroRehabilitation; 2019; 44(2):303-313. PubMed ID: 31006691
[TBL] [Abstract][Full Text] [Related]
24. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS)--from diagnosis to patient care.
Mitchell JD
J Neurol; 2000 Dec; 247():7-12. PubMed ID: 11200703
[TBL] [Abstract][Full Text] [Related]
25. Risk of amyotrophic lateral sclerosis and other motor neuron disease among men with benign prostatic hyperplasia: a population-based cohort study.
Sørensen TT; Horváth-Puhó E; Nørgaard M; Ehrenstein V; Henderson VW
BMJ Open; 2019 Jul; 9(7):e030015. PubMed ID: 31278107
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease.
Dal Bello-Haas V; Florence JM
Cochrane Database Syst Rev; 2013 May; 2013(5):CD005229. PubMed ID: 23728653
[TBL] [Abstract][Full Text] [Related]
27. Motor neurone disease in South Estonia. Diagnosis and incidence rate.
Gross-Paju K; Oöpik M; Lüüs SM; Kalbe I; Puksa L; Lepik T; Kaasik AE
Acta Neurol Scand; 1998 Jul; 98(1):22-8. PubMed ID: 9696523
[TBL] [Abstract][Full Text] [Related]
28. Racial differences in motor neuron disease.
Gundogdu B; Al-Lahham T; Kadlubar F; Spencer H; Rudnicki SA
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):114-8. PubMed ID: 24067242
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study.
Gagliardi D; Faravelli I; Meneri M; Saccomanno D; Govoni A; Magri F; Ricci G; Siciliano G; Pietro Comi G; Corti S
J Cell Mol Med; 2021 Apr; 25(8):3765-3771. PubMed ID: 33609080
[TBL] [Abstract][Full Text] [Related]
30. Repetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron disease.
Fang J; Zhou M; Yang M; Zhu C; He L
Cochrane Database Syst Rev; 2013 May; 2013(5):CD008554. PubMed ID: 23728676
[TBL] [Abstract][Full Text] [Related]
31. Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease.
van der Burgh HK; Westeneng HJ; Meier JM; van Es MA; Veldink JH; Hendrikse J; van den Heuvel MP; van den Berg LH
Neuroimage Clin; 2019; 24():101984. PubMed ID: 31499409
[TBL] [Abstract][Full Text] [Related]
32. Nationwide incidence of motor neuron disease using the French health insurance information system database.
Kab S; Moisan F; Preux PM; Marin B; Elbaz A
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):426-433. PubMed ID: 28387141
[TBL] [Abstract][Full Text] [Related]
33. Using patient-reported symptoms of dyspnea for screening reduced respiratory function in patients with motor neuron diseases.
Helleman J; Kruitwagen-van Reenen ET; Bakers J; Kruithof WJ; van Groenestijn AC; Jaspers Focks RJH; de Grund A; van den Berg LH; Visser-Meily JMA; Beelen A
J Neurol; 2020 Nov; 267(11):3310-3318. PubMed ID: 32577867
[TBL] [Abstract][Full Text] [Related]
34. Toward a marker of upper motor neuron impairment in amyotrophic lateral sclerosis: A fully automatic investigation of the magnetic susceptibility in the precentral cortex.
Contarino VE; Conte G; Morelli C; Trogu F; Scola E; Calloni SF; Sanmiguel Serpa LC; Liu C; Silani V; Triulzi F
Eur J Radiol; 2020 Mar; 124():108815. PubMed ID: 31945675
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease.
Dalbello-Haas V; Florence JM; Krivickas LS
Cochrane Database Syst Rev; 2008 Apr; (2):CD005229. PubMed ID: 18425913
[TBL] [Abstract][Full Text] [Related]
36. Motor neuron disease beginning with frontotemporal dementia: clinical features and progression.
Gromicho M; Kuzma-Kozakiewicz M; Szacka K; Nieporecki K; Andersen PM; Grosskreutz J; Petri S; Pinto S; Uysal H; Swash M; De Carvalho M
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):508-516. PubMed ID: 34229542
[No Abstract] [Full Text] [Related]
37. Clinical, electrodiagnostic, and outcome correlation in ALS patients in Thailand.
Kulkantrakorn K; Suksasunee D
J Clin Neurosci; 2017 Sep; 43():165-169. PubMed ID: 28602631
[TBL] [Abstract][Full Text] [Related]
38. Clinical and prognostic features of ALS/MND in different phenotypes-data from a hospital-based registry.
Wei QQ; Chen Y; Chen X; Cao B; Ou R; Zhang L; Hou Y; Shang H
Brain Res Bull; 2018 Sep; 142():403-408. PubMed ID: 30232045
[TBL] [Abstract][Full Text] [Related]
39. Progressive motor neuron syndromes with single CNS lesions and CSF oligoclonal bands: never forget solitary sclerosis!
Giacopuzzi Grigoli E; Cinnante C; Doneddu PE; Calcagno N; Lenti S; Ciammola A; Maderna L; Ticozzi N; Castellani M; Beretta S; Rovaris M; Silani V; Verde F
Neurol Sci; 2022 Dec; 43(12):6951-6954. PubMed ID: 36121546
[TBL] [Abstract][Full Text] [Related]
40. Physical Activity in People With Motor Neuron Disease: Validity of the Physical Activity Scale for the Elderly as a Measuring Tool.
Sia T; Connors KA; Morgan P
Arch Phys Med Rehabil; 2023 Jan; 104(1):102-107. PubMed ID: 36179894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
